Error: Could not add to watchlist. X
+ Watchlist

Nabriva Therapeutics PLC

NBRV:US
NASDAQ GS
8.35
USD
0.09
1.09%
As of 5:20 PM EDT 9/21/2017
Open
8.36
Day Range
8.25 - 8.48
Volume
1,346,544
Previous Close
8.26
52Wk Range
3.52 - 14.10
1 Yr Return
14.54%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
8.36
Day Range
8.25 - 8.48
Volume
1,346,544
Previous Close
8.26
52Wk Range
3.52 - 14.10
1 Yr Return
14.54%
YTD Return
40.10%
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-18.01
Market Cap (m USD)
308.415
Shares Outstanding (m)
36.629
Price/Sales (TTM)
2.13
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.56%
% Price Change
-0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Nabriva Therapeutics plc operates as a clinical-stage biopharmaceutical company. The Company researches and develops intravenous (IV) and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics serves patients in worldwide.
Address
25-28 North Wall Quay
IFSC
Dublin 1
Ireland
Phone
353-1-649-2000
Show More